Dibenamine: selective protection against diethylnitrosamine-induced hepatic carcinogenesis but not oral, pharyngeal and esophageal carcinogenesis.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003983:Dibenzylchlorethamine / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D009062:Mouth Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D009602:Nitrosamines / Q000037:antagonists & inhibitors*; D009929:Organ Size; D009928:Organ Specificity; D010610:Pharyngeal Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D051381:Rats; D013997:Time Factors
D009602:Nitrosamines; D003983:Dibenzylchlorethamine